Friday, February 22, 2019

Patient Registry Software Market 2018- How the Market will perform in Upcoming Years 2023


According to Meticulous Research®, the Global Patient Registry Software Market will grow at a CAGR of 11.0% to reach USD 1.49 billion by 2023 from 2018, driven by “the rising focus on evidence-based health care, growing need for effective chronic disease management, and increasing use of registries for post-marketing surveillance of drugs and devices.”
This growth is primarily driven by the continued pressure to curtail rising healthcare costs, growing demand to improve care quality, increasing adoption of EHRs and improving health IT infrastructure, growing application of patient registry data in post-marketing surveillance, increasing cancer and rare disease research, and increase in the support from government for value-based care and adoption of patient registries.
Registries are becoming crucial for integrated care models, chronic care management, population health management, and wellness initiatives. The shift to pay-for performance and value-based reimbursement models result in putting the providers at risk of financial losses if the quality and cost targets are not fulfilled. A well designed and executed registry offers hospitals and health systems with vital patient data that enables them in assessing the effectiveness of healthcare services, monitoring patient outcomes, performance benchmarking, regulatory compliance, managing gaps in care, and advance efforts to deliver data-driven evidence-based care. Owing to these reasons, hospitals and medical centers are expected to witness rapid surge in the demand of patient registry software in the coming years.                                      
The global patient registry software market is segmented based on registry type, software type, pricing model, deployment model, database type, functionality, and end-user.


On premise solutions captured a major share owing to concerns related to patient data confidentiality and security on remotely managed servers. On the other hand, cloud-based patient registry solutions are expected to offer high growth opportunities owing to their real time data analysis, easy accessibility, flexibility, scalability, and cost-effectiveness.
The key players in this market are Phytel, Inc., QUINTILES IMS HOLDINGS, INC., Liaison Technologies., ImageTrend, Inc., FIGmd, Inc., McKesson Corporation, CECity.com Inc., Dacima Software Inc., Global Vision Technologies, Inc., ifa systems AG, Syneos Health, M2S, Inc., Optum, Inc. (A part of UnitedHealth Group Incorporated), EVADO Pty. Ltd., and Velos, Inc. among several others.
Download below free sample report to read the entire article. 

Contact –
Khushal Bombe
khushal@meticulousresearch.com
Office No-402, 4th Floor,
Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)



Tuesday, February 19, 2019

$1,016.63 million, North America Natural Sausage Casings Market -Global Opportunity Analysis And Industry Forecast (2018-2025)


According to this latest publication from Meticulous Research®, the North America natural sausage casings market is expected to grow at a CAGR of 3.0% from 2018 to 2025 to reach $1,016.63 million by 2025.

The North America natural sausage casings market is majorly driven by increasing population, urbanization, meat production, and meat consumption across the region; consumer preference to natural casings over artificial casings; and rising number of fast food restaurant chains. However, factors such as increasing preference to artificial casings by sausage manufactures and casings manufactures’ shift from natural casings to artificial casings due to operational challenges is expected to hinder the growth of this market to some extent.

The North America natural sausage casings market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018), and forecasts for 2025 -by Source (Hog, Beef, Sheep, and Other). The study also evaluates industry competitors and analyzes the market at a country level.
                               

On the basis of source, the North America natural sausage casings market is segmented into hog, beef, sheep, and other. Hog casings hold the largest share of the North America natural sausage casings market mainly attributed to the increasing pork sausage production and consumption. However, sheep casings market is expected to witness a rapid growth during the forecast period with the increasing meat consumption and meat production; and its unique properties such as highest quality small diameter, thinner wall, and tenderness.


The key players profiled in the North America natural sausage casings market report are Amjadi GmbH (Germany), Peter Gelhard Naturdärme KG (Germany), World Casing Corporation (U.S.), Natural Casing Company Inc. (U.S.), Oversea DeWied International, LLC. (U.S.), DAT-Schaub Group (Denmark), Combinatie Teijsen V.D. Hengel (the Netherlands), Almol (A/Asia) Casings Pty Ltd. (Australia), AGRIMARES Group (Spain), Carl Lipmann & Co. KG (Germany), Fortis Srl (Italy), SARIA SE & Co. KG (Germany), Rugao Qingfeng Casing Co., Ltd. (China), CDS Hackner GmbH (Germany), Saarland butcher’s supply Strobel GmbH & Co. KG (Germany), and Denison Casing Corporation (U.S.).

To Read Latest News About Research Download Free Sample Report

Contact –

Khushal Bombe
Office No-402, 4th Floor,
Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)



Monday, February 11, 2019

Vaccines Market 2018-2025 | Extensive Analysis On Worldwide Industry and New Market Opportunities


Meticulous Research®, leading global market research company published a research report titled, “The Global Vaccines Market is projected to $57.50 billion by 2025 growing at a CAGR of 7.9% during the forecast period of 2018 to 2025.”
The Global Vaccines Market study presents historical market data in terms of values (2016 and 2017), estimated current data (2018), and forecasts for 2025-Vaccines Market By Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route Of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography.
In 2017, the pneumococcal disease accounted for the largest share of the global vaccines market. The large share of this segment is mainly attributed to the high prevalence of pneumococcal disease in pediatric, elderly, and immunocompromised populations. In addition, growing number of pneumococcal diseases associated with chronic disease patients is further driving the adoption of pneumococcal vaccines. However, meningococcal disease vaccine segment is expected to grow at the highest CAGR in the next 5-7 years.
The growth of this market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines.
The global vaccines market is highly competitive with the presence of many players worldwide. With four big pharmaceutical companies; GSK, Merck & Co., Inc., Pfizer, and Sanofi, the vaccine industry is highly consolidated. CSL Limited, Emergent BioSolutions, Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda and AstraZeneca are the other leading players of the global vaccines market. All these players are focusing more on technologically-advanced vaccine products.
Read full Research Report Study On
North America accounted for the largest share of the vaccines market with its well-established vaccination program. In addition, factors such as the increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players are further expected to propel the growth of vaccines market in this region.The intramuscular accounted for the largest share of the vaccines market. The large share of this segment is mainly due to the availability of wide range of vaccines for IM.            
                 
Key Topics Covered in This Report:
1.    Introduction
2.    Research Methodology
3.    Executive Summary
4.   Market Share Analysis
5.    Market Insights
6.   Global Vaccines Market, by Indication
7.    Global Vaccines Market, by Route of Administration
8.   Global Vaccines Market, by Type/Antigen
9.   Global Vaccines Market, by Valence
10. Vaccines Market, by Region
11. Competitive Landscape
12. Company Profiles
The Asia-Pacific vaccines market is expected to grow at the highest CAGR of 8.9%. The growth in the APAC market is mainly attributed to large patient pool, rising prevalence of diseases, growing awareness on vaccination, increasing government initiatives, and expanding presence of key players in this region. In addition, increasing disposable income and growing awareness about heath in emerging countries are further propelling the demand for vaccines in APAC region.
Hurry Up To Get Your Free Sample Report Now!
Contact –
Khushal Bombe
khushal@meticulousresearch.com
Office No-402, 4th Floor,
Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)

Thursday, February 7, 2019

Favorable Reimbursement Policies for Contrast-Enhanced Procedures Drives the Microbubble/Ultrasound Contrast Agents Market 2024


The Global Microbubbles/Ultrasound Contrast Agents Market will grow at a CAGR of 25.2% from 2018 to 2024 to reach USD 1,584.5 million by 2024, according to the latest publication from Meticulous Research®.
The field of ultrasound contrast imaging has been literally bursting since the last decade. The advancement in ultrasound technologies over the last decade have resulted in widespread usage of ultrasound contrast imaging for clinical applications. This technology is preferred by most researchers due to low-cost, convenience, and real-time capability. In addition, as compared to imaging modalities, ultrasound imaging has good temporal resolution, quantitative data, real-time practice, noninvasiveness, relatively inexpensive, and no ionizing radiation. Also, it was reported by researchers that they help to sharp the image, improve the reliability of the scan, and reduce the need for unnecessary downstream testing. They found to be safe, convenient, completely radiation-free, and versatile. Owing to all these benefits, researchers are trying to use them for diagnostic imaging and other therapeutic areas.
For detail information visit on our web-site


              
The global microbubbles/ultrasound contrast agents market is driven by various factors such as advancement in ultrasound technologies, benefits of ultrasound over alternative technologies, increase in demand for diagnostics & image guided procedures, favorable reimbursement policies for contrast enhanced procedures in the U.S., and growing aging population and subsequent rise in the prevalence of chronic diseases. In addition, rising research activities related to microbubbles/ultrasound contrast agents and emerging economies in the Asia Pacific region provides significant opportunities for various stakeholders in this market.
The global microbubbles/ultrasound contrast agents market studied in this report is majorly segmented on the basis of therapeutic area (cardiovascular diseases, renal and associated diseases, and others), application (molecular imaging, gene therapy, drug delivery, and stem cells delivery), and geography.
The key players analyzed in the microbubble/ultrasound contrast agents market are Lantheus Holdings, Inc. (U.S.), Bracco (Italy), GE Healthcare (U.S.), Daiichi Sankyo Company, Limited (Japan), and nanoPET Pharma GmbH (Germany).
For detail analysis and market values, download free sample report @  
Contact –
Khushal Bombe
khushal@meticulousresearch.com
Office No-402, 4th Floor,
Pushpak Business Hub,
Wakad, Pimpri-Chinchwad, 411057 India.
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)